ScreenPoint Medical
ScreenPoint Medical develops the Transpara Breast AI suite, a vendor-agnostic software platform designed for 2D and 3D mammography. The technology provides automated breast cancer detection, density assessment, and temporal comparison of prior exams to assist radiologists in clinical workflows. The products are FDA cleared and CE marked, targeting breast imaging programs and healthcare providers globally.
Visit websiteNijmegen, Netherlands
Software
Healthcare
HealthTech
Artificial Intelligence
Funding summary
- Total raised
- €35.5M
- Funding rounds
- 2
Investors in ScreenPoint Medical
Investors on record for ScreenPoint Medical. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like ScreenPoint Medical?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors